Skip to main content

Table 3 Sensitivity analyses with adjustment for different confounding factors

From: PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study

 

Adjusted HR (95% CI), P

Model 1a

Model 2b

PIK3CA

 VUSs/WT

Reference

Reference

 Mut

7.5 (1.7–32.4), 0.01

5.4 (1.4–21.7), 0.02

  1. HR Hazard ratio, PIK3CA Gene encoded phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, VUSs Variants of unknown significance, WT Wild type, Mut Pathogenic mutation
  2. aAdjusted for pathological stage and sex
  3. bAdjusted for age and sex
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us